Navigation Links
Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD: Partnership Opportunities in Drug Delivery Conference
Date:7/2/2012

NEW YORK, July 2, 2012 /PRNewswire/ -- In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentations, ranging from novel delivery devices to formulation technologies at the 2nd Annual PODD: Partnership Opportunities in Drug Delivery conference, October 1-2, 2012, at the Boston Park Plaza hotel in Boston, MA.

The PODD program is designed to introduce emerging and enabling drug delivery technologies to help pharmaceutical and biotech drug formulators obtain better clinical outcomes for patients. The PODD event features keynote addresses by two leading scientists in drug delivery, Dr Robert Langer, the David H. Koch Institute Professor, MIT, and Dr. Stephen Oesterle, Senior Vice President for Medicine and Technology, Medtronic.

Dr Barbara Lueckel, Global Business Development Director, Roche returns as the PODD Chairperson. Dr. Lueckel found the inaugural PODD event served as a platform to facilitate innovative collaborations, noting that, "The panels provided an opportunity to gain further insights into companies' thinking on drug delivery partnering and to engage panelists into additional discussions."  She also said, "I am glad we will see more panel discussions in 2012."

Additional industry experts speaking at PODD include:

  • Dr. Sesha Neervannan, Vice President, Pharmaceutical Development, Allergan
  • Dr. Julia Rashba-Step, Senior Director, Novel Delivery Technologies, Pfizer
  • Dr. Anand Subramony, Head of Novel Delivery Technologies & Therapeutics, Novartis
  • Dr. Keith Horspool, Vice President, Pharmaceutical Development, Boehringer Ingelheim

Further highlights of the PODD program include pre-arranged one-on-one partnering meetings, a drug delivery exhibit hall, numerous networking breaks and a reception. Over 250 attendees are anticipated. Companies participating in the 2012 PODD event include Allergan, Aptalis, Becton Dickinson, Boehringer Ingelheim, CIMA Labs, GlaxoSmithKline, Janssen, 3M Drug Delivery Systems, Medtronic, Merck, Novartis, Patheon, Pfizer, Roche and Shire.

For more information, please visit www.theconferenceforum.org or contact Meredith Sands at Msands@theconferenceforum.org or call 646-350-2586.


'/>"/>
SOURCE The Conference Forum
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
2. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
3. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
4. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
5. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
6. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
7. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
8. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
9. Updated: LHA Life Sciences & Medical Technologies Virtual Conference
10. LHA Life Sciences & Medical Technologies Virtual Conference
11. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 2016  A new study highlights the necessity of health literacy within the technology ... American College of Radiology , a majority of oncology patients undergo imaging screenings without ... http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... 2016 Amarantus BioScience Holdings, Inc. ... for Regenerative Medicine, Neurology and Orphan Diseases, today announced that President ... two upcoming investor conferences: SeeThru Equity MicroCap Conference ... New York City , NY When: Tuesday, ... MicroCap Conference   Where: Grand Hyatt Hotel, 109 East ...
(Date:5/26/2016)... 2016   Change Healthcare , a ... solutions and technology-enabled services designed to enable ... a strategic channel partnership with SourceMed, the ... and revenue cycle management services that empower ... clinics to optimize revenue, operational efficiency and ...
Breaking Medicine Technology:
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... needing intervention to walk, the demand for a sustainable product to aid in the ... void and aid in the recovery of individuals with hemiplegia due to stroke. , ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Beleza Medspa ... body fat composition regulations. This is the first time that Coolsculpting is being ... at least every six months to ensure they meet the prescribed body-fat standard, measured ...
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... 2016 , ... On Memorial Day, Hope For Heroes and USA ... battle for the country. The nonprofit Hope For Heroes partnered with the leading ... independence for disabled military veterans, as well as police, firemen, and EMS professionals across ...
Breaking Medicine News(10 mins):